Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023

BUY
$4.45 - $7.57 $3,987 - $6,782
896 New
896 $5,000
Q4 2018

Jan 29, 2019

SELL
$10.72 - $16.73 $589 - $920
-55 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$17.73 - $26.69 $975 - $1,467
55 New
55 $1,000
Q1 2018

May 02, 2018

SELL
$9.0 - $20.16 $360 - $806
-40 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$13.26 - $22.86 $141,205 - $243,436
-10,649 Reduced 99.63%
40 $1,000
Q3 2017

Nov 07, 2017

BUY
$19.76 - $24.9 $209,297 - $263,740
10,592 Added 10919.59%
10,689 $231,000
Q2 2017

Aug 11, 2017

BUY
N/A
97
97 $2,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $647M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Hanseatic Management Services Inc Portfolio

Follow Hanseatic Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hanseatic Management Services Inc with notifications on news.